Where can I find PAIYY's financial statements?

Aesthetic Medical International Holdings Group Limited (PAIYY)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for PAIYY?

Aesthetic Medical International Holdings Group Limited (PAIYY) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does PAIYY update its statements?

Aesthetic Medical International Holdings Group Limited files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

PAIYY

Aesthetic Medical International Holdings Group Limited

OTC·Medical, Care Facilities · Healthcare

$0.01$0.00−14.12%

Pre-market·$0.01+0.00%

Market cap$236.95K·Market closed·Aug 27 2:15 PM UTC

CNY · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	¥645.59M−28.4%	¥670.09M+3.8%	¥682.59M+1.9%	¥755.67M+10.7%	¥703.16M−6.9%
Cost of revenue	¥376.09M+5.4%	¥314.51M−16.4%	¥360.54M+14.6%	¥417.89M+15.9%	¥378.02M−9.5%
Gross profit	¥269.50M−50.5%	¥355.59M+31.9%	¥322.05M−9.4%	¥337.79M+4.9%	¥325.14M−3.7%
General & administrative	¥206.97M−10.3%	¥150.38M−27.3%	¥138.61M−7.8%	¥100.79M−27.3%	—
Selling & marketing	¥404.68M−20.7%	¥226.47M−44.0%	¥232.25M+2.6%	¥241.04M+3.8%	—
SG&A (combined)	¥611.65M−17.5%	¥376.85M−38.4%	¥370.86M−1.6%	¥341.83M−7.8%	¥320.05M−6.4%
Total operating expenses	¥611.65M−17.5%	¥376.85M−38.4%	¥370.86M−1.6%	¥341.83M−7.8%	¥320.05M−6.4%
Operating income	−¥342.15M−74.1%	−¥21.27M+93.8%	−¥48.81M−129.5%	−¥4.04M+91.7%	¥5.09M+226.0%
Interest income	¥113.00K−90.5%	¥155.00K+37.2%	¥78.00K−49.7%	¥404.00K+417.9%	¥134.24K−66.8%
Interest expense	¥27.23M−6.7%	¥21.64M−20.5%	¥14.47M−33.1%	¥8.72M−39.8%	¥8.51M−2.4%
Other income / (expense), net	−¥339.16M−438.2%	−¥72.91M+78.5%	−¥6.25M+91.4%	¥2.70M+143.1%	−¥29.14M−1,181.2%
Income before tax	−¥681.31M−162.6%	−¥94.17M+86.2%	−¥55.06M+41.5%	−¥1.35M+97.6%	−¥24.05M−1,685.1%
Income tax expense	−¥11.80M+6.3%	−¥18.07M−53.1%	−¥15.14M+16.2%	¥23.73M+256.8%	¥28.55M+20.3%
Net income	−¥586.62M−149.1%	−¥76.25M+87.0%	−¥37.43M+50.9%	−¥19.95M+46.7%	−¥51.89M−160.2%

EPS (basic)	−¥80.04−146.4%	−¥8.37+89.5%	−¥2.55+69.5%	−¥1.26+50.6%	−¥3.36−166.7%
EPS (diluted)	−¥80.04−146.4%	−¥8.37+89.5%	−¥2.55+69.5%	−¥1.26+50.6%	−¥3.36−166.7%
Weighted avg shares (basic)	7,328,915	9,101,286	14,628,732	15,944,930	15,944,930
Weighted avg shares (diluted)	7,328,915	9,101,286	14,628,732	15,944,930	15,944,930

Depreciation & amortization	¥99.14M−6.8%	¥61.49M−38.0%	¥65.90M+7.2%	¥65.96M+0.1%	¥57.28M−13.2%
EBITDA	−¥554.95M−347.9%	−¥11.05M+98.0%	¥25.31M+329.0%	¥73.33M+189.7%	¥62.38M−14.9%

Frequently Asked Questions About PAIYY

Where can I find PAIYY's financial statements?: Aesthetic Medical International Holdings Group Limited (PAIYY)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for PAIYY?: Aesthetic Medical International Holdings Group Limited (PAIYY) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does PAIYY update its statements?: Aesthetic Medical International Holdings Group Limited files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Trend

Revenue

¥645.59M−28.4%

¥670.09M+3.8%

¥682.59M+1.9%

¥755.67M+10.7%

¥703.16M−6.9%

Cost of revenue

¥376.09M+5.4%

¥314.51M−16.4%

¥360.54M+14.6%

¥417.89M+15.9%

¥378.02M−9.5%

Gross profit

¥269.50M−50.5%

¥355.59M+31.9%

¥322.05M−9.4%

¥337.79M+4.9%

¥325.14M−3.7%

General & administrative

¥206.97M−10.3%

¥150.38M−27.3%

¥138.61M−7.8%

¥100.79M−27.3%

—

Selling & marketing

¥404.68M−20.7%

¥226.47M−44.0%

¥232.25M+2.6%

¥241.04M+3.8%

—

SG&A (combined)

¥611.65M−17.5%

¥376.85M−38.4%

¥370.86M−1.6%

¥341.83M−7.8%

¥320.05M−6.4%

Total operating expenses

¥611.65M−17.5%

¥376.85M−38.4%

¥370.86M−1.6%

¥341.83M−7.8%

¥320.05M−6.4%

Operating income

−¥342.15M−74.1%

−¥21.27M+93.8%

−¥48.81M−129.5%

−¥4.04M+91.7%

¥5.09M+226.0%

Interest income

¥113.00K−90.5%

¥155.00K+37.2%

¥78.00K−49.7%

¥404.00K+417.9%

¥134.24K−66.8%

Interest expense

¥27.23M−6.7%

¥21.64M−20.5%

¥14.47M−33.1%

¥8.72M−39.8%

¥8.51M−2.4%

Other income / (expense), net

−¥339.16M−438.2%

−¥72.91M+78.5%

−¥6.25M+91.4%

¥2.70M+143.1%

−¥29.14M−1,181.2%

Income before tax

−¥681.31M−162.6%

−¥94.17M+86.2%

−¥55.06M+41.5%

−¥1.35M+97.6%

−¥24.05M−1,685.1%

Income tax expense

−¥11.80M+6.3%

−¥18.07M−53.1%

−¥15.14M+16.2%

¥23.73M+256.8%

¥28.55M+20.3%

Net income

−¥586.62M−149.1%

−¥76.25M+87.0%

−¥37.43M+50.9%

−¥19.95M+46.7%

−¥51.89M−160.2%

EPS (basic)

−¥80.04−146.4%

−¥8.37+89.5%

−¥2.55+69.5%

−¥1.26+50.6%

−¥3.36−166.7%

EPS (diluted)

−¥80.04−146.4%

−¥8.37+89.5%

−¥2.55+69.5%

−¥1.26+50.6%

−¥3.36−166.7%

Weighted avg shares (basic)

7,328,915

9,101,286

14,628,732

15,944,930

Weighted avg shares (diluted)

7,328,915

9,101,286

14,628,732

15,944,930

Depreciation & amortization

¥99.14M−6.8%

¥61.49M−38.0%

¥65.90M+7.2%

¥65.96M+0.1%

¥57.28M−13.2%

EBITDA

−¥554.95M−347.9%

−¥11.05M+98.0%

¥25.31M+329.0%

¥73.33M+189.7%

¥62.38M−14.9%